ABSTRACT
BACKGROUND: Candida albicans (C. albicans) is the most common fungal pathogen that causes clinical infections in humans. This study aimed to evaluate the effects of photodynamic inactivation (PDI) using a 660 nm diode laser along with methyl pheophorbide a, PhotoMed, and PhotoCure as photosensitizer for analyzing the viability of in vitro inactivation of C. albicans Methods: In the PDI group, 20 µL of C. albicans suspension and 20 µL of photosensitizer were inoculated in a 90 mm petri dish (63.6 cm2). The samples were placed in an incubator at 37 °C for 30 min, and then they were irradiated with light (660 nm diode laser, 3 J/cm2). After laser irradiation, the cells were stored for 48 h at 37 °C in an incubator with 5% CO2, and the number of colonies was counted. RESULTS: The highest reduction in the number of colony-forming units per milliliter (CFU/mL) after PDI was observed in the presence of methyl pheophorbide a and PhotoMed, followed by PhotoCure. One-way analysis of variance (ANOVA) demonstrated a significant inhibition (F = 384.717; P < 0.05) for each PDI. CONCLUSIONS: In this study, we demonstrated that the application of PDI to C. albicans using methyl pheophorbide a and PhotoMed resulted in 100% death rates. PDI could be a treatment method because conventional antifungals have limited effects, and they may not eliminate C. albicans completely.
Subject(s)
Candida albicans , Photochemotherapy , Biofilms , Chlorophyll/analogs & derivatives , Humans , Lasers, Semiconductor , Photochemotherapy/methods , Photosensitizing Agents/pharmacologyABSTRACT
[This corrects the article on p. 255 in vol. 9, PMID: 30402381.].
ABSTRACT
OBJECTIVES: Imported systemic mycoses is a severe fungal infection that can cause diseases in healthy people. However, there is a serious lack of epidemiological data about imported systemic mycoses. Therefore, an epidemiological characterization of imported systemic mycoses in Korea was performed. METHODS: We collected health insurance data between 2008 and 2012 from the Health Insurance Corporation and analyzed the data to determine the prevalence and treatment management of imported systemic mycoses. RESULTS: The prevalence of imported systemic mycoses between 2008 and 2012 increased slowly by 0.49/100,000 to 0.53/100,000 persons. The prevalence of coccidioidomycosis increased from 0.28/100,000 in 2008 to 0.36/100,000 persons in 2012. A mean of 229.6 cases occurred each year. Children and the elderly showed higher prevalence than adults in the 20- to 59-year-old age group. The rate of infection according to region ranged from 0.18/100,000 persons in Ulsan, to 0.59/100,000 persons in Gyeonggi. The prevalence in females was higher than that in males. Inpatient treatment was 3.3% (38 cases), with 96.7% treated as outpatients. Hospitalizations cost 272.7 million won and outpatient treatments cost 111.7 million won. The treatment cost for coccidioidomycosis from 2008 to 2012 was 330.9 million won, with personal charges of 79.2 million won and insurance charges of 251.7 million won. Most of the expenses for the coccidioidomycosis treatment were for inpatient treatment. CONCLUSION: The results in this study may be a useful resource for determining the changes in the trend of imported systemic mycoses.
